Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa
- PMID: 16401616
- DOI: 10.1093/brain/awl005
Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa
Abstract
Parkinson's disease is a frequent disorder caused primarily by the loss of dopaminergic neurons of the substantia nigra. Mutations in the PTEN-induced kinase (PINK1) gene, in addition to those in parkin and DJ-1, have been found in families with recessive early-onset Parkinson's disease. We screened for parkin and PINK1 mutations in a panel of 177 autosomal recessive Parkinson's disease families with ages at onset < or =60 years, mostly from Europe. In 7 unrelated families, we identified 10 pathogenic PINK1 mutations (5 missense, 2 nonsense and 3 frameshift deletion mutations), 8 of which were novel. All the mutations were in the homozygous or compound heterozygous states. Interestingly, pseudo-dominant inheritance was observed in a family with two different mutations. The clinical characteristics of 12 PINK1 patients and 114 parkin patients were similar, even for signs such as dystonia at onset and increased reflexes, which were thought to be specific to parkin. In contrast, onset in patients with PINK1 mutations was earlier and increased reflexes were found more frequently than in patients without PINK1 or parkin mutations. These results suggest that PINK1 is the second most frequent causative gene in early-onset Parkinson's disease with a slowly progressive phenotype, indistinguishable from early-onset patients with parkin mutations.
Similar articles
-
Significance of the parkin and PINK1 gene in Jordanian families with incidences of young-onset and juvenile parkinsonism.BMC Neurol. 2008 Dec 16;8:47. doi: 10.1186/1471-2377-8-47. BMC Neurol. 2008. PMID: 19087301 Free PMC article.
-
Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease.Mov Disord. 2009 Jan 30;24(2):196-203. doi: 10.1002/mds.22287. Mov Disord. 2009. PMID: 18973254
-
Clinicogenetic study of PINK1 mutations in autosomal recessive early-onset parkinsonism.Neurology. 2005 Jun 14;64(11):1955-7. doi: 10.1212/01.WNL.0000164009.36740.4E. Neurology. 2005. PMID: 15955953
-
[Molecular genetics of PINK1].Brain Nerve. 2007 Aug;59(8):831-8. Brain Nerve. 2007. PMID: 17713119 Review. Japanese.
-
Autosomal recessive parkinsonism.Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S4-6. doi: 10.1016/S1353-8020(11)70004-9. Parkinsonism Relat Disord. 2012. PMID: 22166450 Review.
Cited by
-
Neurogenomics in Africa: Perspectives, progress, possibilities and priorities.J Neurol Sci. 2016 Jul 15;366:213-223. doi: 10.1016/j.jns.2016.05.006. Epub 2016 May 6. J Neurol Sci. 2016. PMID: 27288810 Free PMC article. Review.
-
Tom20 gates PINK1 activity and mediates its tethering of the TOM and TIM23 translocases upon mitochondrial stress.Proc Natl Acad Sci U S A. 2024 Mar 5;121(10):e2313540121. doi: 10.1073/pnas.2313540121. Epub 2024 Feb 28. Proc Natl Acad Sci U S A. 2024. PMID: 38416681 Free PMC article.
-
Cognitive Impairment in Genetic Parkinson's Disease.Parkinsons Dis. 2021 Dec 30;2021:8610285. doi: 10.1155/2021/8610285. eCollection 2021. Parkinsons Dis. 2021. PMID: 35003622 Free PMC article. Review.
-
Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease.Am J Hum Genet. 2008 Apr;82(4):822-33. doi: 10.1016/j.ajhg.2008.01.015. Epub 2008 Mar 20. Am J Hum Genet. 2008. PMID: 18358451 Free PMC article.
-
Diagnosis and treatment of Parkinson disease: molecules to medicine.J Clin Invest. 2006 Jul;116(7):1744-54. doi: 10.1172/JCI29178. J Clin Invest. 2006. PMID: 16823471 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials